Filing Details
- Accession Number:
- 0001645842-22-000013
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-02-03 18:15:41
- Reporting Period:
- 2022-02-01
- Accepted Time:
- 2022-02-03 18:15:41
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1645842 | Zymergen Inc. | ZY | Services-Commercial Physical & Biological Research (8731) | 462942439 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1845645 | Aaron Kimball | 5980 Horton Street, Suite 105 Emeryville CA 94608 | Chief Technology Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2022-02-01 | 25,000 | $5.06 | 770,283 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 17, 2021.
- Transaction executed in multiple trades at prices ranging from $4.93 to $5.25 per share, inclusive. The price reported in column 4 above reflects the weighted average sale price per share. The Reporting Person hereby undertakes to provide the SEC staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
Billionaire Hedge Funds
